Erin Frazee Barreto, Pharm.D., MSc
Acute Kidney Injury and Renal Replacement Therapy in the Critical Ill Patient
Dr. Erin Frazee is a critical care clinical pharmacist in the medical and surgical/trauma ICUs at Mayo Clinic, Rochester, MN. She received her PharmD degree from Drake University in Des Moines Iowa. Thereafter, Dr. Frazee completed Pharmacy Practice and Critical Care Residencies at Mayo Clinic and attained Board Certification as a Critical Care Clinical Pharmacist in 2010. She serves as the Assistant Program Director for Mayo Clinic’s PGY2 Critical Care Pharmacy Residency and is active in local, regional, and national pharmacy and multidisciplinary organizations. Dr. Frazee's research focuses on the impact of renal function on medication use in the critically ill and she has authored many peer-reviewed publications in this field.
Stephanie Bass, Pharm.D.
Hepatic Failure/GI/Endocrine Emergencies
Dr. Stephanie Bass is a Medical ICU Clinical Pharmacist at Cleveland Clinic in Cleveland, Ohio.
Dr. Bass is responsible for daily multidisciplinary rounds with critical care teams to provide evidence-based recommendations in order to optimize pharmacotherapy, prevent adverse effects, and ensure cost-effective medication use. Additional responsibilities include providing drug information and education to allied health staff and conducting medication use evaluations and research projects.
She received her PharmD from the University of North Carolina in 2011 and did her PGY1 Pharmacy Practice Residency as well as her PGY2 Critical Care Residency at Cleveland Clinic.
Seth R. Bauer, Pharm.D., FCCM, FCCP
Shock Syndromes & Sepsis I: Vasodilatory and Sepsis
Dr. Seth R. Bauer is a Critical Care Clinical Coordinator at Cleveland Clinic, Cleveland, Ohio. He completed his undergraduate work and his Pharm.D. degree at Drake University in Des Moines, Iowa. Thereafter, Dr. Bauer completed residencies in pharmacy practice and critical care at Mayo Clinic in Rochester, Minnesota. He attained board certification in pharmacotherapy in 2006 and in critical care in 2015.
Dr. Bauer’s clinical practice is in a 64-bed medical ICU with a patient volume and acuity level near the highest in the United States. His research interests include sepsis and shock therapeutics, with several publications in these areas. Dr. Bauer co-wrote the 2014 PSAP chapter on “Severe Sepsis and Septic Shock” and the 2017 CCSAP chapter on "Management of Circulatory Shock." He is an active member of the Society of Critical Care Medicine Clinical Pharmacy and Pharmacology section and the Critical Care Pharmacotherapy Trials Network.
Scott T. Benken, Pharm.D., BCPS
Acute Cardiac Care
Dr. Scott T. Benken is a clinical pharmacist in the medical ICU at the University of Illinois Hospital & Health Sciences System in Chicago, Illinois, and a clinical assistant professor at the University of Illinois at Chicago College of Pharmacy. He received his Pharm.D. degree from the University of Cincinnati, James L. Winkle College of Pharmacy, in Cincinnati, Ohio. Thereafter, Dr. Benken completed residencies in pharmacy practice and critical care at the University of Illinois Hospital & Health Sciences System.
Dr. Benken’s clinical and research interests involve the optimization of medication therapy in critically ill patients as well as the exploration of medication regimens in unique critically ill patient subsets. He enjoys collaborative research endeavors as well as experiential teaching; he especially appreciates didactic classroom opportunities throughout the pharmacy curriculum. Dr. Benken is board certified in pharmacotherapy, and in 2014, he joined the ACCP Critical Care Pharmacy Preparatory Review Course faculty.
“I once heard surviving a sudden cardiac arrest described as “being given a second chance” or a survivor’s stating that “there must be something left to accomplish.” Whatever the perspective may be, having the knowledge and skills to participate in resuscitation and revival is crucial for every critical care pharmacist. Our patients deserve the best of what we know and can offer to make sudden cardiac arrest “something they will never remember, but also something they will never forget.””
Bradley A. Boucher, Pharm.D., FCCP, BCPS
Critical Care Pharmacy Evolution and Validation, Practice Standards, Training, and Professional Development
Dr. Bradley A. Boucher is currently a professor of clinical pharmacy and an associate dean for strategic initiatives and operations at the University of Tennessee College of Pharmacy in Memphis, Tennessee. He practices in the area of critical care at the Regional Medical Center and is board certified in pharmacotherapy. Dr. Boucher has published more than 80 peer-reviewed articles and 18 book chapters during his career.
Dr. Boucher received his B.S. and Pharm.D. degrees from the University of Minnesota, Minneapolis, Minnesota, in 1979 and 1983, respectively. Then in 1984, he completed an American Society of Health-System Pharmacists critical care fellowship at the University of Kentucky in Lexington, Kentucky. Dr. Boucher became board certified in pharmacotherapy in 1992. He was elected as a Fellow of ACCP in 1998 and of the American College of Critical Care Medicine in February 2000. In 2004, Dr. Boucher distinguished himself by being elected as a pharmacy member of the National Academy of Practitioners. In addition, Dr. Boucher received the 2011 ACCP Clinical Practice Award.
Relative to professional service, Dr. Boucher served as the president of ACCP in 2002 and received the ACCP Service Award in 2004. Dr. Boucher was elected as the National Rho Chi president-elect in 2014. He is currently on the editorial board of the journal Critical Care Research and Practice.
“The specialty of critical care pharmacy has grown during the past half-century from consisting of a handful of visionary pharmacists practicing in a variety of critical care settings to becoming the standard of care for intensive care units in the United States. The leadership of the pioneering critical care pharmacists has not only led to the pharmacy profession’s formal recognition within the interdisciplinary world of critical care, but has also resulted in several studies documenting the value of critical care pharmacists relative to improving patient care. This ranges from a reduction in drug and overall medical costs, as well as adverse drug effects/drug interactions, to improvements in patient morbidity and mortality. The evolution of critical care pharmacy has been fueled by exponential growth in the training and credentialing of practitioners and researchers within this specialty area. The culmination of this growth is evidenced by BPS recognition of critical care pharmacy as a specialty in 2013. Framing the core knowledge base areas and skills needed for success as a critical care pharmacist is the focus of the newly crafted ACCP Critical Care Pharmacy Preparatory and Review Course.”
Mitchell S. Buckley, Pharm.D., FCCM, FCCP
Mitchell S. Buckley is a clinical pharmacy specialist in the medical ICU and serves as the PGY1 residency director at Banner University Medical Center in Phoenix, Arizona. Dr. Buckley received his Pharm.D. degree from the University of Iowa. He completed an ASHP-accredited PGY1 pharmacy practice residency at Shawnee Mission Medical Center and a PGY2 critical care specialty residency at the University of Arizona. He has written several peer-reviewed publications in pharmacy and medical journals as well as book chapters related to critical care. He is actively involved in several international professional organizations. He has served as chair of the ACCP Critical Care PRN and the SCCM CPP Patient Safety and Research committees as well as the ASHP critical care network facilitator. Dr. Buckley recently served as a member of the 2017 ACCP Annual Programming Committee. Dr. Buckley received the 2013 ACCP Critical Care PRN Member Research Grant, 2014 ASHP Best Practice Award, 2015 SCCM CPP Section Excellence in Using Technology to Improve ICU Medication Safety Award, and 2016 ASHP Foundation Literature Award in pharmacy practice research. He currently leads multidisciplinary teams at his institution on several process improvement strategies. Dr. Buckley’s clinical and research interests include stress ulcer prophylaxis, pulmonary hypertension, septic shock, nosocomial pneumonia, sedation/delirium management, and medication safety in ICU patients.
Aaron Cook, PharmD, BCPS, BCCCP
Dr. Aaron Cook is the coordinator for the neuroscience-pulmonary/critical care team at the University of Kentucky Medical Center in Lexington, Kentucky, and an adjunct associate professor at the University of Kentucky College of Pharmacy. Dr. Cook received his Pharm.D. degree from the University of Kentucky in 2000 and subsequently completed 2 years of residency training, specializing in critical care, at the University of Kentucky.
In addition to his clinical practice, Dr. Cook coordinates the critical care module in the Pharm.D. core curriculum, a critical care elective course, and the Advanced Pharmacotherapy Gateway Program for students interested in residency and postgraduate training. He is also the PGY1 pharmacy residency program director at the University of Kentucky Medical Center and precepts the inpatient neurosurgery and neurology rotations for APPE students as well as for PGY1 and PGY2 residents.
Dr. Cook is active in scholarship, particularly that related to neurocritical care and pharmacy residency training, as well as in professional service activities in the Neurocritical Care Society and the Kentucky Society of Health-System Pharmacists.
James Coons, PharmD, FCCP, BCCP
Cardiovascular Critical Care
Jim Coons is an Associate Professor at the University of Pittsburgh School of Pharmacy and a clinical pharmacist specializing in cardiology at UPMC Presbyterian Hospital. He is a Board-Certified Pharmacotherapy Specialist, with Added Qualifications in Cardiology Pharmacotherapy. He also directs the PGY-2 Cardiology Pharmacy Residency Program at UPMC. His current practice and research interests focus on the management of patients with acute coronary syndromes that undergo percutaneous coronary intervention (PCI) as well as those with advanced heart failure and pulmonary vascular diseases. His current efforts focus on the clinical implementation of pharmacogenomics at UPMC Presbyterian Hospital in patients that undergo PCI.
Mitchell J. Daley, Pharm.D., BCPS
Shock Syndromes & Sepsis II: Hypovolemic, Critical Bleeding, and Obstructive
Mitchell J. Daley is a market critical care clinical pharmacy specialist for Seton Healthcare Family in Austin, Texas. He provides direct patient care at Dell Seton Medical Center at the University of Texas in the trauma/surgical or medical ICU while supporting clinical administrative projects for the Seton Healthcare Network and Ascension Health. He completed his Pharm.D. degree at the University of Wyoming, followed by PGY1 pharmacy practice and PGY2 critical care pharmacy residencies at the University of Chicago Medicine. Thereafter, he obtained board certification in pharmacotherapy and holds a clinical adjunct faculty appointment with the University of Texas College of Pharmacy, where he precepts pharmacy residents and students in the adult ICU. Recently, he was inducted as a fellow with the American College of Critical Care Medicine.
Daley’s scholarly interests include thrombolysis in acute pulmonary embolism, anticoagulation reversal in life-threatening hemorrhage, circulatory shock, pharmacotherapy in the trauma ICU, and the impact of medications on thromboelastography. He has presented on and published numerous research and reviews related to this subject material and currently co-leads the management of shock syndromes for the ACCP review course for board preparation. In addition, he has led efforts to optimize patient outcomes related to thrombolytics in pulmonary embolism, management of septic shock, anticoagulation/antiplatelet reversal, and pharmacotherapy in massive transfusion protocol across the Seton Healthcare Network. He is a member of the ACCP Critical Care PRN and the Society of Critical Care Medicine Clinical Pharmacy and Pharmacology section. He is a past chair of the SCCM CPP Research Committee and currently serves as a taskforce member of the ACCP/SCCM critical care pharmacy services position statement.
Roland N. Dickerson, Pharm.D., FCCP,BCNSP
Fluids, Electrolytes, Acid Base Disorders, and Nutrition Support
Dr. Roland Dickerson is Professor of Clinical Pharmacy at the University of Tennessee College of Pharmacy, Clinical Coordinator and Clinical Pharmacist for the Nutrition Support Service at Regional One Health (formerly Regional Medical Center) in Memphis, TN. Prior to arriving in Memphis in 1992, he was Clinical Pharmacist in Nutrition Support at the Hospital of the University of Pennsylvania from 1983 to 1988 and a faculty member at the University of Sciences in Philadelphia from 1988 to 1992. Dickerson received his B.S. in Pharmacy from Temple University in 1979 and Doctor of Pharmacy from the University of Tennessee in 1982. He completed a hospital pharmacy residency at Thomas Jefferson University Hospital in Philadelphia from 1979 to 1980 and a fellowship in pharmacy nutrition support at the University of North Carolina in Chapel Hill from 1982 to 1983.
Dr. Dickerson has authored over 170 publications, 19 book chapters, 100 scientific abstracts and given 230 invited presentations throughout the U.S. and the world. He has trained 66 advanced pharmacy residents, research fellows, and international pharmacists in Nutrition Support/Critical Care. Dickerson is a board certified nutrition support pharmacist and a fellow of the American College of Clinical Pharmacy, American Society of Health-Systems Pharmacists, American College of Critical Care Medicine, and American Society for Parenteral and Enteral Nutrition. He has served on the editorial boards of JPEN Journal of Parenteral and Enteral Nutrition, Journal of the American College of Nutrition, and Hospital Pharmacy and currently serves on the editorial boards of Nutrition and Nutrition in Clinical Practice. He is a scientific reviewer for numerous medical, nutrition, and pharmacy journals. Dickerson is a recipient of multiple honors including the Clinical Practice Award from the American College of Clinical Pharmacy, Jonathan Rhoads Lecture Award from the American Society for Parenteral and Enteral Nutrition, John M. Kinney International Nutrition award, and the American Society of Health-System Pharmacists’ Sustained Contributions to the Literature award.
Dr. Dickerson has been a member of ACCP since 1992 and attended his first ACCP meeting with a research poster presentation in 1987.
“The provision of nutrition support, fluid and electrolyte therapy, glycemic control, and management of metabolic-based acid-base disorders, often termed metabolic support, has been the responsibility of many clinical pharmacists engaged in the care of critically ill patients for more than 4 decades. Three of the top five high-alert medications identified by ISMP as causing potential patient harm (insulin, potassium chloride or phosphate, and hypertonic saline) are part of the metabolic support armamentarium. Critical care pharmacists are uniquely qualified to serve in a leadership role in these activities, not just because medical school training is often limited in this area but also because metabolic support emulates the same principles that guide pharmaceutical care. That is, insufficient doses will be ineffective, doses too high will be toxic, therapy needs to be individualized, intense monitoring is warranted, and dosing adjustment is often indicated.”
Stephanie Dwyer, PharmD
Acute Cardiac Care
Dr. Stephanie Dwyer is a Cardiovascular Clinical Pharmacist at the University of Illinois Hospital and Health Sciences System and a Clinical Assistant Professor at the University of Illinois at Chicago College of Pharmacy (UIC COP). Dr. Dwyer received her PharmD from UIC COP, where she studied at the Rockford campus. She completed her PGY1 at the Captain James A. Lovell Federal Health Care Center and her PGY2 Cardiology Residency at UIC. Within cardiology, her areas of interest include heart failure, arrhythmias, valvular disease, and transitions of care.
Amy L. Dzierba, Pharm.D., BCPS
Supportive and Preventative Medicine; Pulmonary Disorders
Amy L. Dzierba received her Pharm.D. degree in 2000 from the Midwestern University School of Pharmacy in Downers Grove, Illinois. In 2001, she completed a PGY1 pharmacy residency at Grady Health System in Atlanta, Georgia, followed by a PGY2 pharmacy residency in critical care at the University of Washington/Harborview Medical Center in Seattle, Washington.
Currently, Dr. Dzierba is a clinical pharmacist in the medical ICU as at the New York-Presbyterian Hospital (NYPH) in New York, New York. In 2007, she established the NYPH pharmacy residency program in critical care, where she still serves as the program director. In addition, Dr. Dzierba has an appointment as an instructor at the Columbia University School of Nursing in New York City, New York, and has served as a member of the Columbia University Medical Center Investigational Review Board for more than 7 years.
“This review course is a complete package for critical care pharmacists preparing to take the certification exam. Chapters, written by experts, include images and test questions that provide a comprehensive knowledge base for each participant.”
Curtis E. Haas, Pharm.D., FCCP, BCPS
Critical Care Pharmacy Evolution and Validation, Practice Standards, Training, and Professional Development
Curtis E. Haas is the director of pharmacy for the University of Rochester Medical Center (URMC) in Rochester, New York. He received his B.S. degree from the Albany College of Pharmacy in Albany, New York, in 1982, and completed his Pharm.D. degree at the University at Buffalo in Buffalo, New York, in 1989. Haas spent the first 18 years of his professional career in the acute care environment, progressing through many clinical, administrative, and research responsibilities ranging from a staff pharmacist to the director of the Clinical Pharmacology Trials Unit. In 2000, he joined the faculty at the School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, where he was eventually promoted to an associate professor with tenure. In 2006, Haas accepted his current position at URMC. For 17 years, he specialized in critical care pharmacy practice and maintained an active teaching, practice, and research program. His many professional service activities include ACCP past president and board member and appointment to the Pharmacotherapy Specialty Council of the Board of Pharmacy Specialties. He has been involved in the training and education of pharmacy students, residents, and fellows for more than 20 years.
Lisa G. Hall Zimmerman, BCCCP,BCPS,BCNSP,FCC
Practice Management and Development: Protocol Development and Quality Improvement
Dr. Lisa Hall Zimmerman is the PGY2 Critical Care Residency Program Director and a critical care / nutrition support clinical pharmacist at New Hanover Regional Medical Center in Wilmington, North Carolina. Dr. Hall Zimmerman received her B.S. degree in Pharmacy from Auburn University in Auburn, Alabama, and subsequently her Pharm.D. degree from Samford University, Birmingham, Alabama. She completed a PGY2 Critical Care pharmacy residency at Mayo Clinic in Rochester, Minnesota.
Dr. Hall Zimmerman is a fellow of critical care medicine and is board certified in critical care pharmacy, pharmacotherapy, and nutrition support pharmacy. In addition, Dr. Hall Zimmerman is a member of ACCP, the Society of Critical Care Medicine, the American Society for Parenteral and Enteral Nutrition, and the American Society of Health-System Pharmacists.
She has been a residency program director for the PGY2 critical care pharmacy residency and an interim residency program director for the PGY2 emergency medicine pharmacy residency program at the Detroit Medical Center at the Detroit Receiving Hospital in Detroit, Michigan.
Dr. Hall Zimmerman has written and presented papers on infections in the critically ill, surgical infections, pain, nutrition support and metabolic management, and vasopressin. Dr. Hall Zimmerman’s research interests include septic shock, hemodynamic support, infections in the critically ill, and surgical/trauma.
“Topics with protocol development and quality assurance will cover how to develop, promote, and justify critical care pharmacy services as well as how to design protocol, develop practice standards, and evaluate quality to promote best practice in the critical care environment. Other topics in this section include identifying the metrics for evaluating critical care pharmacy services and national quality programs.”
Sandra L. Kane-Gill, Pharm.D., MSc, FCCP
Practice Management: Medication Safety and Pharmacoeconomics
Sandra L. Kane-Gill is a professor of pharmacy and therapeutics at the University of Pittsburgh School of Pharmacy. She has secondary appointments in the school of medicine in the Clinical Translational Science Institute, Department of Critical Care Medicine, and Department of Biomedical Informatics. She also serves as an associate professor for the Center for Critical Care Nephrology and Center for Pharmaceutical Policy and Prescribing. In addition to her academic appointments, Kane-Gill is a critical care medication safety pharmacist at the UPMC Department of Pharmacy. Her research focuses on effective approaches for detecting, preventing, and managing medication errors and adverse drug events. She has successfully incorporated health information technology (clinical decision support, telemedicine) into practice to advance health care systems, ensuring better safety and quality of care for patients. Kane-Gill is actively working on an AHRQ R18 grant to transform the medication regimen review process of high-risk drugs using a patient-centered telemedicine-based approach to prevent adverse drug events (R18HS02420-01).
At the 2011 ACCP Annual Meeting, Kane-Gill received the Critical Care PRN Research Award and, in 2013, the Critical Care Achievement Award. At the 2015 SCCM Annual Congress, she was recognized for her contributions in medication safety error prevention with the Clinical Pharmacy and Pharmacology Section Technology Patient Safety Award. Her work has been presented at several professional meetings, and she has published over 150 articles and book chapters related to critical care and patient safety. She is on the editorial boards for Critical Care Medicine, Annals of Pharmacotherapy, and Hospital Pharmacy (critical care column).
Simon Lam, PharmD, FCCM, BCCCP
Infectious Diseases II
Dr. Simon Lam is currently a medical ICU clinical specialist at Cleveland Clinic, Cleveland, Ohio. His clinical practice site is a 64-bed progressive ICU within a tertiary academic medical center. In addition to his clinical responsibilities, he is the chair of the departmental research committee and the co-chair of the residency research team.
Dr. Lam earned his Pharm.D. degree from Rutgers University in Piscataway, New Jersey. Thereafter, he completed his pharmacy practice residency at New York-Presbyterian Hospital in New York, New York, and his critical care residency at Mayo Clinic in Rochester, Minnesota. He attained board certification in pharmacotherapy in 2008. His research interests include sepsis therapeutics and infectious disease issues in the critically ill population. He has several publications and book chapters in these topic areas, including the 2014 PSAP chapter on “Severe Sepsis and Septic Shock.”
Ishaq Lat, Pharm.D., FCCP, BCPS
Research Design and Literature Evaluation
Dr. Ishaq Lat is the associate director of clinical pharmacy services and a clinical pharmacist specialist in Critical Care at Rush University Medical Center. He received his Pharm.D. degree in 2002 from the University of Missouri-Kansas City; completed his American Society of Health-System Pharmacists (ASHP)-accredited PGY1 pharmacy residency at Emory Healthcare in Atlanta, Georgia; and completed his ASHP-accredited PGY2 critical care residency at Indiana University Health in Indianapolis, Indiana.
Dr. Lat currently serves as associate director for clinical pharmacy services at Rush University Center. Dr. Lat founded and served as the program director for the PGY2 Critical Care residency at University of Chicago Medical Center before departing for his position at Rush University Medical Center. His clinical and research interests include shock syndromes, pharmacokinetics in critically ill patients, and sedation/analgesia/delirium in mechanically ventilated patients. Dr. Lat has written several research manuscripts, review articles, and book chapters on these topics. In addition, Dr. Lat currently chairs the Critical Care Pharmacotherapy Trials Network, a group dedicated to collaborative research for critically ill patients. Dr. Lat is also an active member of ACCP and the Society of Critical Care Medicine.
“With a field as rapidly evolving as critical care pharmacotherapy, the planning committee took great care in carefully selecting core areas for inclusion in the review course to maximize the participant’s experience. The intent of the review course is to prepare the participant for passing the certification exam while providing cutting-edge material from renowned faculty. The textbook material combined with the live didactic presentation will make for a thorough and comprehensive experience.”
Eric W. Mueller, Pharm.D., FCCM, FCCP
Infectious Diseases I
Dr. Eric W. Mueller is the assistant director of clinical pharmacy services and research at the University of Cincinnati Medical Center (UCMC) and an adjunct associate professor of pharmacy practice at the University of Cincinnati, Cincinnati, Ohio. Dr. Mueller has practiced as a clinical pharmacy specialist in critical care at UCMC since 2005. Dr. Mueller also serves as the director of the PGY2 critical care pharmacy residency program. Dr. Mueller received his B.S. (1999) and Pharm.D. (2001) degrees from the University of Cincinnati and completed his critical care/nutrition support residency (2002) and critical care research fellowship (2004) at the University of Tennessee Health Science Center in Memphis, Tennessee.
Dr. Mueller’s interdisciplinary clinical practice is primarily in critically ill surgical/trauma and medical patients. Dr. Mueller’s main clinical research interests and productivity are in infectious disease, pharmacokinetics/pharmacodynamics, anticoagulation, patient comfort, and outcome-driven process improvement. Dr. Mueller serves as a preceptor for PGY1 and PGY2 pharmacy residents and APPE students, and he is an interdisciplinary educator for critical care nurses and physicians. Dr. Mueller is active in pharmacy and critical care–related professional organizations, including service in leadership roles in ACCP, the Society of Critical Care Medicine, and the Critical Care Pharmacotherapy Trials Network.
Megan E. Musselman, PharmD,MS,BCPS,BCCCP
Megan E. Musselman is the emergency medicine/critical care clinical pharmacy specialist at North Kansas City Hospital in Kansas City, Missouri. She is adjunct faculty at the University of Kansas and University of Missouri-Kansas City schools of pharmacy. In addition, she serves as the PGY1 residency and advanced practice pharmacy student coordinator for North Kansas City Hospital. Musselman received her Pharm.D. degree from Creighton University School of Pharmacy and Health Professions. After completing her degree, she completed PGY1 residency training at the University of Illinois at Chicago and PGY2 residency training in emergency medicine at Detroit Receiving Hospital. She has also earned a master’s degree in clinical toxicology from the University of Florida. In her current position, Musselman has been responsible for establishing pharmacy clinical services in the emergency department and establishing best practices in the ICU at North Kansas City Hospital.
Musselman served as the 2012–2013 treasurer/secretary of the Emergency Medicine PRN, started the EMED PRN Award and Recognition Committee in fall 2013, and is the immediate past chair of the EMED PRN. She has presented her work at national meetings, served as a speaker at numerous national and regional conferences, and published in pharmacy and medical literature. Since 2013, Musselman has volunteered to serve as an emergency medicine item writer for the ACCP Clinical Pharmacy Challenge. In addition, she has served as the American Society of Health-System Pharmacists emergency medicine network facilitator for the Section of Clinical Specialists and Scientists.
Andrea M. Nei, PharmD
Acute Kidney Injury and Renal Replacement Therapy in the Critical Ill Patient
Andrea Nei received her Doctor of Pharmacy degree from South Dakota State University. She completed her PGY-1 Pharmacy Residency and PGY-2 Critical Care Pharmacy Residency at Mayo Clinic in Rochester, MN. She is a Board Certified Pharmacotherapy Specialist and Board Certified Critical Care Pharmacist. Andrea currently practices as a critical care pharmacist in the medical and surgical/trauma intensive care units at Mayo Clinic. Her research and professional interests include nephrology and renal replacement therapy, shock, anticoagulation and coagulopathy. She is actively involved in research leadership at Mayo Clinic and serves as the Mayo Midwest Pharmacy Research Committee Vice Chair and Scientific Review Subcommittee Chair.
Joanna L. Stollings, Pharm.D, FCCM, FCCP
Management of Pain, Agitation, Delirium, and Neuromuscular Blockade in Adult Intensive Care Unit Patients
Dr. Joanna L. Stollings is the Medical Intensive Care Unit Clinical Pharmacy Specialist at the Vanderbilt University Medical Center, Nashville, Tennessee. Dr. Stollings is the pharmacist for the Vanderbilt University Medical Center Post ICU Recovery Center and Delirium and Cognitive Impairment Study Group. She also is affiliate pharmacy faculty at Belmont University College of Pharmacy, Lipscomb University College of Pharmacy, and University of Tennessee College of Pharmacy. She received her PharmD from West Virginia University School of Pharmacy. She then completed a Pharmacy Practice Residency at Charleston Area Medical Center in Charleston, West Virginia and a Critical Care Pharmacy Residency at Mayo Clinic in Rochester, Minnesota.
Dr. Stollings’s research interests include pharmacotherapy of agents used for analgesia, sedation, and delirium, non-pharmacologic methods used in the prevention of delirium, strategies to facilitate ventilator weaning, and post intensive care syndrome. Dr. Stollings has written several research manuscripts, review articles, and book chapters on these topics. In addition, Dr. Stollings serves on the executive committee of the Society of Critical Care Medicine’s (SCCM) ICU Liberation Collaborative, a group whose mission is to establish the ABCDEF bundle in 77 hospitals in the United States. She also is a member of SCCM THRIVE whose mission is to improve patent and family illness following critical illness through providing education to providers, patients, and families and by establishing support groups and post intensive care syndrome clinics throughout the United States. Dr. Stollings is also an active member of ACCP and SCCM.
Joseph M. Swanson, Pharm.D., FCCM, FCCP
Joseph M. Swanson is an associate professor of clinical pharmacy and an associate professor of pharmacology at the University of Tennessee College of Pharmacy and College of Medicine, respectively, in Memphis, Tennessee. Dr. Swanson received his Pharm.D. degree from the University of Tennessee in 2002. In 2003, he completed an American Society of Health-System Pharmacists (ASHP)-accredited pharmacy practice residency at the Regional Medical Center in Memphis, Tennessee. He furthered his training with a 1-year critical care/nutrition support specialty residency at the Elvis Presley Trauma Center in Memphis, Tennessee, and a 2-year critical care fellowship at the University of Tennessee. In 2006, Dr. Swanson joined the faculty at the University of Tennessee.
Dr. Swanson has more than 35 peer-reviewed publications and 6 first-edition book chapters. His research interests include pharmacotherapy and infectious complications in critically ill patients, and he has served as the principal or coinvestigator for research funded through ASHP, the Society of Infectious Diseases Pharmacists, and the pharmaceutical industry. Dr. Swanson has given lectures related to critical care and infectious diseases at local, regional, and national meetings. He has been board certified in pharmacotherapy since 2005. He currently maintains a clinical practice at the level 1 trauma center (Elvis Presley Trauma Center) at Regional One Health in Memphis, Tennessee. He lectures to pharmacy students throughout the curriculum and is a preceptor in the trauma critical care APPEs.